| 3351 |
Acute Sulfur Mustard Exposure |
NM |
IL6 |
UP |
Case-Control |
Healthy Control |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
|
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3352 |
Acute Sulfur Mustard Exposure |
NM |
IL6 |
UP |
Case-Control |
Healthy Control |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
|
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3353 |
Acute Sulfur Mustard Exposure |
NM |
IL6 |
UP |
Case-Control |
Healthy Control |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
|
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3354 |
Acute Sulfur Mustard Exposure |
NM |
CXCL8 |
UP |
Case-Control |
Healthy Control |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
|
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3355 |
Acute Sulfur Mustard Exposure |
NM |
CXCL8 |
UP |
Case-Control |
Healthy Control |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
|
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3356 |
Acute Sulfur Mustard Exposure |
NM |
CXCL8 |
UP |
Case-Control |
Healthy Control |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
|
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3357 |
Acute Sulfur Mustard Exposure |
NM |
IL6 |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
pre-treatment with GSH |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3358 |
Acute Sulfur Mustard Exposure |
NM |
IL6 |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
pre-treatment with GSH |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3359 |
Acute Sulfur Mustard Exposure |
NM |
IL6 |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
pre-treatment with GSH |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3360 |
Acute Sulfur Mustard Exposure |
NM |
IL6 |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
pre-treatment with GSH |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3361 |
Acute Sulfur Mustard Exposure |
NM |
IL6 |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
pre-treatment with GSH |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3362 |
Acute Sulfur Mustard Exposure |
NM |
IL6 |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
pre-treatment with GSH |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3363 |
Acute Sulfur Mustard Exposure |
NM |
IL6 |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
simultaneous treatment with GSH |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3364 |
Acute Sulfur Mustard Exposure |
NM |
IL6 |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
simultaneous treatment with GSH |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3365 |
Acute Sulfur Mustard Exposure |
NM |
IL6 |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
simultaneous treatment with GSH |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3366 |
Acute Sulfur Mustard Exposure |
NM |
IL6 |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
simultaneous treatment with GSH |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3367 |
Acute Sulfur Mustard Exposure |
NM |
IL6 |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
simultaneous treatment with GSH |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3368 |
Acute Sulfur Mustard Exposure |
NM |
IL6 |
NC |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
pre-treatment with NAC |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3369 |
Acute Sulfur Mustard Exposure |
NM |
IL6 |
NC |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
pre-treatment with NAC |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3370 |
Acute Sulfur Mustard Exposure |
NM |
IL6 |
NC |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
pre-treatment with NAC |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3371 |
Acute Sulfur Mustard Exposure |
NM |
IL6 |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
pre-treatment with NAC |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3372 |
Acute Sulfur Mustard Exposure |
NM |
IL6 |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
pre-treatment with NAC |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3373 |
Acute Sulfur Mustard Exposure |
NM |
IL6 |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
pre-treatment with NAC |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3374 |
Acute Sulfur Mustard Exposure |
NM |
IL6 |
NC |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
pre-treatment with NAC |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3375 |
Acute Sulfur Mustard Exposure |
NM |
IL6 |
UP |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
pre-treatment with NAC |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3376 |
Acute Sulfur Mustard Exposure |
NM |
IL6 |
UP |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
pre-treatment with NAC |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3377 |
Acute Sulfur Mustard Exposure |
NM |
IL6 |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
simultaneous treatment with NAC |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3378 |
Acute Sulfur Mustard Exposure |
NM |
IL6 |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
simultaneous treatment with NAC |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3379 |
Acute Sulfur Mustard Exposure |
NM |
IL6 |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
simultaneous treatment with NAC |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3380 |
Acute Sulfur Mustard Exposure |
NM |
IL6 |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
simultaneous treatment with NAC |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3381 |
Acute Sulfur Mustard Exposure |
NM |
IL6 |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
simultaneous treatment with NAC |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3382 |
Acute Sulfur Mustard Exposure |
NM |
IL6 |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
simultaneous treatment with NAC |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3383 |
Acute Sulfur Mustard Exposure |
NM |
IL6 |
UP |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
simultaneous treatment with NAC |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3384 |
Acute Sulfur Mustard Exposure |
NM |
IL6 |
UP |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
simultaneous treatment with NAC |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3385 |
Acute Sulfur Mustard Exposure |
NM |
IL6 |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
simultaneous treatment with NAC |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3386 |
Acute Sulfur Mustard Exposure |
NM |
CXCL8 |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
pre-treatment with GSH |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3387 |
Acute Sulfur Mustard Exposure |
NM |
CXCL8 |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
pre-treatment with GSH |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3388 |
Acute Sulfur Mustard Exposure |
NM |
CXCL8 |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
pre-treatment with GSH |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3389 |
Acute Sulfur Mustard Exposure |
NM |
CXCL8 |
NC |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
simultaneous treatment with GSH |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3390 |
Acute Sulfur Mustard Exposure |
NM |
CXCL8 |
NC |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
simultaneous treatment with GSH |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3391 |
Acute Sulfur Mustard Exposure |
NM |
CXCL8 |
NC |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
simultaneous treatment with GSH |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3392 |
Acute Sulfur Mustard Exposure |
NM |
CXCL8 |
UP |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
simultaneous treatment with GSH |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3393 |
Acute Sulfur Mustard Exposure |
NM |
CXCL8 |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
pre-treatment with NAC |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3394 |
Acute Sulfur Mustard Exposure |
NM |
CXCL8 |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
pre-treatment with NAC |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3395 |
Acute Sulfur Mustard Exposure |
NM |
CXCL8 |
UP |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
pre-treatment with NAC |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3396 |
Acute Sulfur Mustard Exposure |
NM |
CXCL8 |
UP |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
pre-treatment with NAC |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3397 |
Acute Sulfur Mustard Exposure |
NM |
CXCL8 |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
simultaneous treatment with NAC |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3398 |
Acute Sulfur Mustard Exposure |
NM |
CXCL8 |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
simultaneous treatment with NAC |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3399 |
Acute Sulfur Mustard Exposure |
NM |
CXCL8 |
NC |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
simultaneous treatment with NAC |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3400 |
Acute Sulfur Mustard Exposure |
NM |
CXCL8 |
NC |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
simultaneous treatment with NAC |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3401 |
Acute Sulfur Mustard Exposure |
NM |
CXCL8 |
NC |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
simultaneous treatment with NAC |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3402 |
Acute Sulfur Mustard Exposure |
NM |
CXCL8 |
UP |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
simultaneous treatment with NAC |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3403 |
Acute Sulfur Mustard Exposure |
NM |
CXCL8 |
UP |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
simultaneous treatment with NAC |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3488 |
Acute Sulfur Mustard Exposure |
NM |
IL6 |
NC |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
>0.05 |
|
in vitro |
Homo sapiens |
pre-treatment with GSH |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3489 |
Acute Sulfur Mustard Exposure |
NM |
IL6 |
NC |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
>0.05 |
|
in vitro |
Homo sapiens |
pre-treatment with GSH |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3490 |
Acute Sulfur Mustard Exposure |
NM |
IL6 |
NC |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
>0.05 |
|
in vitro |
Homo sapiens |
pre-treatment with GSH |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3491 |
Acute Sulfur Mustard Exposure |
NM |
IL6 |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
>0.05 |
|
in vitro |
Homo sapiens |
simultaneous treatment with GSH |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3492 |
Acute Sulfur Mustard Exposure |
NM |
IL6 |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
>0.05 |
|
in vitro |
Homo sapiens |
simultaneous treatment with GSH |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3493 |
Acute Sulfur Mustard Exposure |
NM |
IL6 |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
>0.05 |
|
in vitro |
Homo sapiens |
simultaneous treatment with GSH |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3494 |
Acute Sulfur Mustard Exposure |
NM |
IL6 |
UP |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
>0.05 |
|
in vitro |
Homo sapiens |
simultaneous treatment with GSH |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3495 |
Acute Sulfur Mustard Exposure |
NM |
CXCL8 |
NC |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
>0.05 |
|
in vitro |
Homo sapiens |
pre-treatment with GSH |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3496 |
Acute Sulfur Mustard Exposure |
NM |
CXCL8 |
NC |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
>0.05 |
|
in vitro |
Homo sapiens |
pre-treatment with GSH |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3497 |
Acute Sulfur Mustard Exposure |
NM |
CXCL8 |
NC |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
>0.05 |
|
in vitro |
Homo sapiens |
pre-treatment with GSH |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3498 |
Acute Sulfur Mustard Exposure |
NM |
CXCL8 |
NC |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
>0.05 |
|
in vitro |
Homo sapiens |
pre-treatment with GSH |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3499 |
Acute Sulfur Mustard Exposure |
NM |
CXCL8 |
NC |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
>0.05 |
|
in vitro |
Homo sapiens |
pre-treatment with GSH |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3500 |
Acute Sulfur Mustard Exposure |
NM |
CXCL8 |
NC |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
>0.05 |
|
in vitro |
Homo sapiens |
pre-treatment with GSH |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3501 |
Acute Sulfur Mustard Exposure |
NM |
CXCL8 |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
>0.05 |
|
in vitro |
Homo sapiens |
simultaneous treatment with GSH |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3502 |
Acute Sulfur Mustard Exposure |
NM |
CXCL8 |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
>0.05 |
|
in vitro |
Homo sapiens |
simultaneous treatment with GSH |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3503 |
Acute Sulfur Mustard Exposure |
NM |
CXCL8 |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
>0.05 |
|
in vitro |
Homo sapiens |
simultaneous treatment with GSH |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3504 |
Acute Sulfur Mustard Exposure |
NM |
CXCL8 |
NC |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
>0.05 |
|
in vitro |
Homo sapiens |
simultaneous treatment with GSH |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3505 |
Acute Sulfur Mustard Exposure |
NM |
CXCL8 |
NC |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
>0.05 |
|
in vitro |
Homo sapiens |
simultaneous treatment with GSH |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3506 |
Acute Sulfur Mustard Exposure |
NM |
CXCL8 |
NC |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
>0.05 |
|
in vitro |
Homo sapiens |
pre-treatment with NAC |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3507 |
Acute Sulfur Mustard Exposure |
NM |
CXCL8 |
NC |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
>0.05 |
|
in vitro |
Homo sapiens |
pre-treatment with NAC |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3508 |
Acute Sulfur Mustard Exposure |
NM |
CXCL8 |
NC |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
>0.05 |
|
in vitro |
Homo sapiens |
pre-treatment with NAC |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3509 |
Acute Sulfur Mustard Exposure |
NM |
CXCL8 |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
>0.05 |
|
in vitro |
Homo sapiens |
pre-treatment with NAC |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3510 |
Acute Sulfur Mustard Exposure |
NM |
CXCL8 |
NC |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
>0.05 |
|
in vitro |
Homo sapiens |
pre-treatment with NAC |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3511 |
Acute Sulfur Mustard Exposure |
NM |
CXCL8 |
NC |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
>0.05 |
|
in vitro |
Homo sapiens |
simultaneous treatment with NAC |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3512 |
Acute Sulfur Mustard Exposure |
NM |
CXCL8 |
NC |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
>0.05 |
|
in vitro |
Homo sapiens |
simultaneous treatment with NAC |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 4878 |
Acute Sulfur Mustard Exposure |
NM |
necrosis |
UP |
Case-Control |
Healthy Control |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
|
Phenotype |
0 |
0 |
luminescence cytotoxicity assay |
NM |
| 4879 |
Acute Sulfur Mustard Exposure |
NM |
necrosis |
UP |
Case-Control |
Healthy Control |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
|
Phenotype |
0 |
0 |
luminescence cytotoxicity assay |
NM |
| 4880 |
Acute Sulfur Mustard Exposure |
NM |
necrosis |
UP |
Case-Control |
Healthy Control |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
|
Phenotype |
0 |
0 |
luminescence cytotoxicity assay |
NM |
| 4881 |
Acute Sulfur Mustard Exposure |
NM |
necrosis |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
Necrosis pre-treatment with GSH |
Phenotype |
0 |
0 |
luminescence cytotoxicity assay |
NM |
| 4882 |
Acute Sulfur Mustard Exposure |
NM |
necrosis |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
Necrosis pre-treatment with GSH |
Phenotype |
0 |
0 |
luminescence cytotoxicity assay |
NM |
| 4883 |
Acute Sulfur Mustard Exposure |
NM |
necrosis |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
Necrosis pre-treatment with GSH |
Phenotype |
0 |
0 |
luminescence cytotoxicity assay |
NM |
| 4884 |
Acute Sulfur Mustard Exposure |
NM |
necrosis |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
Necrosis pre-treatment with GSH |
Phenotype |
0 |
0 |
luminescence cytotoxicity assay |
NM |
| 4885 |
Acute Sulfur Mustard Exposure |
NM |
necrosis |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
Necrosis simultaneous treatment with GSH |
Phenotype |
0 |
0 |
luminescence cytotoxicity assay |
NM |
| 4886 |
Acute Sulfur Mustard Exposure |
NM |
necrosis |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
Necrosis simultaneous treatment with GSH |
Phenotype |
0 |
0 |
luminescence cytotoxicity assay |
NM |
| 4887 |
Acute Sulfur Mustard Exposure |
NM |
necrosis |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
Necrosis simultaneous treatment with GSH |
Phenotype |
0 |
0 |
luminescence cytotoxicity assay |
NM |
| 4888 |
Acute Sulfur Mustard Exposure |
NM |
necrosis |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
Necrosis simultaneous treatment with GSH |
Phenotype |
0 |
0 |
luminescence cytotoxicity assay |
NM |
| 4889 |
Acute Sulfur Mustard Exposure |
NM |
necrosis |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
Necrosis simultaneous treatment with GSH |
Phenotype |
0 |
0 |
luminescence cytotoxicity assay |
NM |
| 4890 |
Acute Sulfur Mustard Exposure |
NM |
necrosis |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
Necrosis simultaneous treatment with GSH |
Phenotype |
0 |
0 |
luminescence cytotoxicity assay |
NM |
| 4891 |
Acute Sulfur Mustard Exposure |
NM |
necrosis |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
Necrosis simultaneous treatment with GSH |
Phenotype |
0 |
0 |
luminescence cytotoxicity assay |
NM |
| 4892 |
Acute Sulfur Mustard Exposure |
NM |
necrosis |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
Necrosis simultaneous treatment with GSH |
Phenotype |
0 |
0 |
luminescence cytotoxicity assay |
NM |
| 4893 |
Acute Sulfur Mustard Exposure |
NM |
necrosis |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
Necrosis simultaneous treatment with GSH |
Phenotype |
0 |
0 |
luminescence cytotoxicity assay |
NM |
| 4894 |
Acute Sulfur Mustard Exposure |
NM |
necrosis |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
Necrosis pre-treatment with NAC |
Phenotype |
0 |
0 |
luminescence cytotoxicity assay |
NM |
| 4895 |
Acute Sulfur Mustard Exposure |
NM |
necrosis |
NC |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
Necrosis pre-treatment with NAC |
Phenotype |
0 |
0 |
luminescence cytotoxicity assay |
NM |
| 4896 |
Acute Sulfur Mustard Exposure |
NM |
necrosis |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
Necrosis pre-treatment with NAC |
Phenotype |
0 |
0 |
luminescence cytotoxicity assay |
NM |
| 4897 |
Acute Sulfur Mustard Exposure |
NM |
necrosis |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
Necrosis pre-treatment with NAC |
Phenotype |
0 |
0 |
luminescence cytotoxicity assay |
NM |
| 4898 |
Acute Sulfur Mustard Exposure |
NM |
necrosis |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
Necrosis pre-treatment with NAC |
Phenotype |
0 |
0 |
luminescence cytotoxicity assay |
NM |
| 4899 |
Acute Sulfur Mustard Exposure |
NM |
necrosis |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
Necrosis pre-treatment with NAC |
Phenotype |
0 |
0 |
luminescence cytotoxicity assay |
NM |
| 4900 |
Acute Sulfur Mustard Exposure |
NM |
necrosis |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
Necrosis simultaneous treatment with NAC |
Phenotype |
0 |
0 |
luminescence cytotoxicity assay |
NM |
| 4901 |
Acute Sulfur Mustard Exposure |
NM |
necrosis |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
Necrosis simultaneous treatment with NAC |
Phenotype |
0 |
0 |
luminescence cytotoxicity assay |
NM |
| 4902 |
Acute Sulfur Mustard Exposure |
NM |
necrosis |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
Necrosis simultaneous treatment with NAC |
Phenotype |
0 |
0 |
luminescence cytotoxicity assay |
NM |
| 4903 |
Acute Sulfur Mustard Exposure |
NM |
necrosis |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
Necrosis simultaneous treatment with NAC |
Phenotype |
0 |
0 |
luminescence cytotoxicity assay |
NM |
| 4904 |
Acute Sulfur Mustard Exposure |
NM |
necrosis |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
Necrosis simultaneous treatment with NAC |
Phenotype |
0 |
0 |
luminescence cytotoxicity assay |
NM |
| 4905 |
Acute Sulfur Mustard Exposure |
NM |
necrosis |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
Necrosis simultaneous treatment with NAC |
Phenotype |
0 |
0 |
luminescence cytotoxicity assay |
NM |
| 4906 |
Acute Sulfur Mustard Exposure |
NM |
necrosis |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
Necrosis simultaneous treatment with NAC |
Phenotype |
0 |
0 |
luminescence cytotoxicity assay |
NM |
| 4907 |
Acute Sulfur Mustard Exposure |
NM |
necrosis |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
Necrosis simultaneous treatment with NAC |
Phenotype |
0 |
0 |
luminescence cytotoxicity assay |
NM |
| 4908 |
Acute Sulfur Mustard Exposure |
NM |
necrosis |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
Necrosis simultaneous treatment with NAC |
Phenotype |
0 |
0 |
luminescence cytotoxicity assay |
NM |
| 4909 |
Acute Sulfur Mustard Exposure |
NM |
necrosis |
NC |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
>0.05 |
|
in vitro |
Homo sapiens |
Necrosis pre-treatment with GSH |
Phenotype |
0 |
0 |
luminescence cytotoxicity assay |
NM |
| 4910 |
Acute Sulfur Mustard Exposure |
NM |
necrosis |
NC |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
>0.05 |
|
in vitro |
Homo sapiens |
Necrosis pre-treatment with GSH |
Phenotype |
0 |
0 |
luminescence cytotoxicity assay |
NM |
| 4911 |
Acute Sulfur Mustard Exposure |
NM |
necrosis |
NC |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
>0.05 |
|
in vitro |
Homo sapiens |
Necrosis pre-treatment with GSH |
Phenotype |
0 |
0 |
luminescence cytotoxicity assay |
NM |
| 4912 |
Acute Sulfur Mustard Exposure |
NM |
necrosis |
NC |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
>0.05 |
|
in vitro |
Homo sapiens |
Necrosis pre-treatment with GSH |
Phenotype |
0 |
0 |
luminescence cytotoxicity assay |
NM |
| 4913 |
Acute Sulfur Mustard Exposure |
NM |
necrosis |
NC |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
>0.05 |
|
in vitro |
Homo sapiens |
Necrosis pre-treatment with GSH |
Phenotype |
0 |
0 |
luminescence cytotoxicity assay |
NM |
| 4914 |
Acute Sulfur Mustard Exposure |
NM |
necrosis |
NC |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
>0.05 |
|
in vitro |
Homo sapiens |
Necrosis pre-treatment with NAC |
Phenotype |
0 |
0 |
luminescence cytotoxicity assay |
NM |
| 4915 |
Acute Sulfur Mustard Exposure |
NM |
necrosis |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
>0.05 |
|
in vitro |
Homo sapiens |
Necrosis pre-treatment with NAC |
Phenotype |
0 |
0 |
luminescence cytotoxicity assay |
NM |
| 4916 |
Acute Sulfur Mustard Exposure |
NM |
necrosis |
NC |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
>0.05 |
|
in vitro |
Homo sapiens |
Necrosis pre-treatment with NAC |
Phenotype |
0 |
0 |
luminescence cytotoxicity assay |
NM |
| 6824 |
Acute Sulfur Mustard Exposure |
NM |
apoptotic cell |
UP |
Case-Control |
Healthy Control |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
|
Phenotype |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 6825 |
Acute Sulfur Mustard Exposure |
NM |
apoptotic cell |
UP |
Case-Control |
Healthy Control |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
|
Phenotype |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 6826 |
Acute Sulfur Mustard Exposure |
NM |
apoptotic cell |
UP |
Case-Control |
Healthy Control |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
|
Phenotype |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 6827 |
Acute Sulfur Mustard Exposure |
NM |
apoptotic cell |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
Apoptosis simultaneous treatment with GSH |
Phenotype |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 6828 |
Acute Sulfur Mustard Exposure |
NM |
apoptotic cell |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
Apoptosis simultaneous treatment with GSH |
Phenotype |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 6829 |
Acute Sulfur Mustard Exposure |
NM |
apoptotic cell |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
Apoptosis simultaneous treatment with GSH |
Phenotype |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 6830 |
Acute Sulfur Mustard Exposure |
NM |
apoptotic cell |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
Apoptosis simultaneous treatment with GSH |
Phenotype |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 6831 |
Acute Sulfur Mustard Exposure |
NM |
apoptotic cell |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
Apoptosis simultaneous treatment with GSH |
Phenotype |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 6832 |
Acute Sulfur Mustard Exposure |
NM |
apoptotic cell |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
Apoptosis simultaneous treatment with GSH |
Phenotype |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 6833 |
Acute Sulfur Mustard Exposure |
NM |
apoptotic cell |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
Necrosis simultaneous treatment with NAC |
Phenotype |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 6834 |
Acute Sulfur Mustard Exposure |
NM |
apoptotic cell |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
Necrosis simultaneous treatment with NAC |
Phenotype |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 6835 |
Acute Sulfur Mustard Exposure |
NM |
apoptotic cell |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
Necrosis simultaneous treatment with NAC |
Phenotype |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 6836 |
Acute Sulfur Mustard Exposure |
NM |
apoptotic cell |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
Necrosis simultaneous treatment with NAC |
Phenotype |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 6837 |
Acute Sulfur Mustard Exposure |
NM |
apoptotic cell |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
Necrosis simultaneous treatment with NAC |
Phenotype |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 6838 |
Acute Sulfur Mustard Exposure |
NM |
apoptotic cell |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
Necrosis simultaneous treatment with NAC |
Phenotype |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 6839 |
Acute Sulfur Mustard Exposure |
NM |
apoptotic cell |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
Necrosis simultaneous treatment with NAC |
Phenotype |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 6840 |
Acute Sulfur Mustard Exposure |
NM |
apoptotic cell |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
Necrosis simultaneous treatment with NAC |
Phenotype |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 6841 |
Acute Sulfur Mustard Exposure |
NM |
apoptotic cell |
DOWN |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
Necrosis simultaneous treatment with NAC |
Protein |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 6905 |
Acute Sulfur Mustard Exposure |
NM |
apoptotic cell |
NC |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
>0.05 |
|
in vitro |
Homo sapiens |
Apoptosis simultaneous treatment with GSH |
Phenotype |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 6906 |
Acute Sulfur Mustard Exposure |
NM |
apoptotic cell |
NC |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
>0.05 |
|
in vitro |
Homo sapiens |
Apoptosis simultaneous treatment with GSH |
Phenotype |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 6907 |
Acute Sulfur Mustard Exposure |
NM |
apoptotic cell |
NC |
Case-Control |
Untreated cells |
Acute Sulfur Mustard Exposure |
>0.05 |
|
in vitro |
Homo sapiens |
Apoptosis simultaneous treatment with GSH |
Phenotype |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |